J. Biol. Chem., Vol. 266, Issue 27, 17919-17925, 09, 1991

Structural basis of specific and efficient phosphorylation of peptides derived from p34cdc2 by a pp60src-related protein tyrosine kinase

HC Cheng, CM Litwin, DM Hwang and JH Wang
Department of Medical Biochemistry, Faculty of Medicine, University of Calgary, Alberta, Canada.

Cys-cdc2(8-20), a synthetic peptide derived from p34cdc2, was previously reported to be a specific and efficient substrate of a pp60c- src-related tyrosine kinase isolated from bovine spleen (the spleen tyrosine kinase) (Litwin, C.M.E., Cheng, H.-C., and Wang, J.H. (1991) J. Biol. Chem. 266, 2557-2566). The longer peptide, cdc2(1-24), was found to be phosphorylated by the kinase with similar efficiency, and Tyr15 was the only amino acid residue phosphorylated. This indicated that the amino acid sequence of cdc2(8-20) peptide, EKI-GEGTYGVVYK, contained the structural features important for protein tyrosine kinase substrate activity. A stepwise procedure using synthetic peptides was employed to investigate such structural features. First, a computer search of protein sequences homologous to cdc2(8-20) uncovered five protein kinases containing homologous sequence with tyrosine at a position corresponding to Tyr15 of p34cdc2. Second, a peptide derived from ribosomal S6 protein kinase (rsk(436-456] was synthesized. The rsk(436-456) peptide contained a segment, ETIGVGSYSVCKR, which is highly homologous to that of cdc2(8-20). It was found to be a very poor substrate of the spleen tyrosine kinase. Third, peptide analogs of cdc2(6-20) with single substitutions of amino acid residues Lys9, Glu12, Thr14, Gly16, Val18, and Tyr19 by amino acid residues at corresponding positions of rsk were synthesized and tested as spleen tyrosine kinase substrates. Only Glu12 and Thr14 substituted peptide analogs showed decreased substrate activities. (The substrate activity of a peptide is the ability of the peptide to serve as the substrate of the spleen tyrosine kinase. It was determined of the spleen tyrosine kinase. It was determined either by the kinetic parameters (Km and Vmax) of phosphorylation of the peptide or by the initial phosphorylation rate of the peptide by the spleen tyrosine kinase.) An analog with double substitution at Glu12 An analog with double substitution at Glu12 and Thr14 was found to be almost as poor a substrate as the rsk peptide. In addition, peptide analogs with Tyr15 substituted by Phe or D-Tyr had poor substrate activities as well as weak inhibitory activities. Thus, Glu12, Thr14, and Tyr15 residues of p34cdc2 contained structural components essential for the efficient phosphorylation of the peptides derived from p34cdc2 by the pp60c-src- related spleen tyrosine kinase.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y.-P. Chong, T. D. Mulhern, H.-J. Zhu, D. J. Fujita, J. D. Bjorge, J.-P. Tantiongco, N. Sotirellis, D. S. S. Lio, G. Scholz, and H.-C. Cheng A Novel Non-catalytic Mechanism Employed by the C-terminal Src-homologous Kinase to Inhibit Src-family Kinase Activity J. Biol. Chem., May 14, 2004; 279(20): 20752 - 20766. [Abstract] [Full Text] [PDF]

				R. V. S. Rajala and R. E. Anderson Interaction of the Insulin Receptor {beta}-Subunit with Phosphatidylinositol 3-Kinase in Bovine ROS Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3110 - 3117. [Abstract] [Full Text] [PDF]

				H. Tang, T. Nishishita, T. Fitzgerald, E. J. Landon, and T. Inagami Inhibition of AT1 Receptor Internalization by Concanavalin A Blocks Angiotensin II-induced ERK Activation in Vascular Smooth Muscle Cells. INVOLVEMENT OF EPIDERMAL GROWTH FACTOR RECEPTOR PROTEOLYSIS BUT NOT AT1 RECEPTOR INTERNALIZATION J. Biol. Chem., April 28, 2000; 275(18): 13420 - 13426. [Abstract] [Full Text] [PDF]

				K. Murakami, S. Sato, S. Nagasawa, and T. Yamashita Regulation of mast cell signaling through high-affinity IgE receptor by CD45 protein tyrosine phosphatase Int. Immunol., February 1, 2000; 12(2): 169 - 176. [Abstract] [Full Text] [PDF]

				H. Tang, Z. J. Zhao, X.-Y. Huang, E. J. Landon, and T. Inagami Fyn Kinase-directed Activation of SH2 Domain-containing Protein-tyrosine Phosphatase SHP-2 by Gi Protein-coupled Receptors in Madin-Darby Canine Kidney Cells J. Biol. Chem., April 30, 1999; 274(18): 12401 - 12407. [Abstract] [Full Text] [PDF]

				A. I. Ibitayo, Y. Tsunoda, F. Nozu, C. Owyang, and K. N. Bitar Src kinase and PI 3-kinase as a transduction pathway in ceramide-induced contraction of colonic smooth muscle Am J Physiol Gastrointest Liver Physiol, October 1, 1998; 275(4): G705 - G711. [Abstract] [Full Text] [PDF]

				H. Tang, D. F. Guo, J. P. Porter, Y. Wanaka, and T. Inagami Role of Cytoplasmic Tail of the Type 1A Angiotensin II Receptor in Agonist– and Phorbol Ester–Induced Desensitization Circ. Res., March 23, 1998; 82(5): 523 - 531. [Abstract] [Full Text] [PDF]

				N. Sotirellis, T. M. Johnson, M. L. Hibbs, I. J. Stanley, E. Stanley, A. R. Dunn, and H.-C. Cheng Autophosphorylation Induces Autoactivation and a Decrease in the Src Homology 2 Domain Accessibility of the Lyn Protein Kinase J. Biol. Chem., December 15, 1995; 270(50): 29773 - 29780. [Abstract] [Full Text] [PDF]

				T. M. Johnson, N. A. Williamson, G. Scholz, A. Jaworowski, R. E. H. Wettenhall, A. R. Dunn, and H.-C. Cheng Modulation of the Catalytic Activity of the Src Family Tyrosine Kinase Hck by Autophosphorylation at a Novel Site in the Unique Domain J. Biol. Chem., October 20, 2000; 275(43): 33353 - 33364. [Abstract] [Full Text] [PDF]

				B. M. Vonakis, H. Haleem-Smith, P. Benjamin, and H. Metzger Interaction between the Unphosphorylated Receptor with High Affinity for IgE and Lyn Kinase J. Biol. Chem., January 5, 2001; 276(2): 1041 - 1050. [Abstract] [Full Text] [PDF]